Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 7, 2015; 21(37): 10697-10703
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10697
Table 1 Baseline characteristics (n = 153) n (%)
Age (yr), median (IQR)72 (60-79)
Age > 70 yr82 (54)
Sex, M/F102 (67)/51 (33)
Current smoker41 (27)
Current drinker108 (71)
NSAIDs41 (27)
> 1 mo administration27 (18)
Low-dose aspirin ( ≤ 100 mg)38 (25)
> 1 mo administration38 (25)
Non-aspirin antiplatelets29 (19)
> 1 mo administration28 (18)
Sarpogrelate hydrochloride2 (0.3)
Ethyl icosapentate1 (0.7)
Dilazep1 (0.7)
Ticlopidine6 (3.9)
Clopidogrel10 (6.5)
Cilostazol10 (6.5)
Limaprost alfadex2 (5.6)
Dipyridamole1 (0.7)
Limaprost1 (0.7)
Warfarin10 (7.0)
> 1 m administration8 (5.0)
Acetaminophen2 (1.3)
> 1 mo administration1 (0.7)
Corticosteroids5 (3.3)
> 1 mo administration5 (3.3)
Hypertension98 (64)
Diabetes mellitus31 (20)
Dyslipidemia32 (21)
Cerebro-cardio vascular disease40 (26)
Chronic liver disease6 (3.9)
Chronic kidney disease13 (8.5)